A 24‐Week, Randomized, Controlled Trial of Rivastigmine Patch 13.3 mg/24 h Versus 4.6 mg/24 h in Severe Alzheimer's Dementia

por Farlow, Martin R., Grossberg, George T., Sadowsky, Carl H., Meng, Xiangyi, Somogyi, Monique
Publicado 2013

Alzheimer’s Disease Diagnosis by Detecting Exogenous Fluorescent Signal of Ligand Bound to Beta Amyloid in the Lens of Human Eye: An Exploratory Study

por Kerbage, Charles, Sadowsky, Carl H., Jennings, Danna, Cagle, Gerald D., Hartung, Paul D.
Publicado 2013

A clinical trial to validate event-related potential markers of Alzheimer's disease in outpatient settings

por Cecchi, Marco, Moore, Dennis K., Sadowsky, Carl H., Solomon, Paul R., Doraiswamy, P. Murali, Smith, Charles D., Jicha, Gregory A., Budson, Andrew E., Arnold, Steven E., Fadem, Kalford C.
Publicado 2015

The S-Connect study: results from a randomized, controlled trial of Souvenaid in mild-to-moderate Alzheimer’s disease

por Shah, Raj C, Kamphuis, Patrick J, Leurgans, Sue, Swinkels, Sophie H, Sadowsky, Carl H, Bongers, Anke, Rappaport, Stephen A, Quinn, Joseph F, Wieggers, Rico L, Scheltens, Philip, Bennett, David A
Publicado 2013

Performance of [(18)F]flutemetamol amyloid imaging against the neuritic plaque component of CERAD and the current (2012) NIA-AA recommendations for the neuropathologic diagnosis of...

por Salloway, Stephen, Gamez, Jose E., Singh, Upinder, Sadowsky, Carl H., Villena, Teresa, Sabbagh, Marwan N., Beach, Thomas G., Duara, Ranjan, Fleisher, Adam S., Frey, Kirk A., Walker, Zuzana, Hunjan, Arvinder, Escovar, Yavir M., Agronin, Marc E., Ross, Joel, Bozoki, Andrea, Akinola, Mary, Shi, Jiong, Vandenberghe, Rik, Ikonomovic, Milos D., Sherwin, Paul F., Farrar, Gill, Smith, Adrian P.L., Buckley, Christopher J., Thal, Dietmar Rudolf, Zanette, Michelle, Curtis, Craig
Publicado 2017